DrugPatentWatch Database Preview
Drugs in Development Information for Bardoxolone methyl
Email this page to a colleague
» See Plans and PricingWhat is the development status for investigational drug Bardoxolone methyl?
Bardoxolone methyl is an investigational drug.
There have been 27 clinical trials for Bardoxolone methyl.
The most recent clinical trial was a Phase 2 trial, which was initiated on May 30th 2018.
The most common disease conditions in clinical trials are Kidney Diseases, Renal Insufficiency, Chronic, and Diabetes Mellitus, Type 2. The leading clinical trial sponsors are Reata Pharmaceuticals, Inc., Kyowa Kirin Co., Ltd., and Kyowa Hakko Kirin Company, Limited.
There are sixteen US patents protecting this investigational drug and fifty-nine international patents.
Summary for Bardoxolone methyl
| US Patents | 16 |
| International Patents | 59 |
| US Patent Applications | 21 |
| WIPO Patent Applications | 11 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2018-05-30) |
| Vendors | 75 |
Recent Clinical Trials for Bardoxolone methyl
| Title | Sponsor | Phase |
|---|---|---|
| Phase I Study of RTA 402 in Obese Adults | Kyowa Kirin Co., Ltd. | Phase 1 |
| A Trial of Bardoxolone Methyl in Patients With ADPKD - FALCON | Reata Pharmaceuticals, Inc. | Phase 3 |
| A Clinical Pharmacology Study of Bardoxolone Methyl in Healthy Adults | Kyowa Kirin Co., Ltd. | Phase 1 |
Clinical Trial Summary for Bardoxolone methyl
Top disease conditions for Bardoxolone methyl
Top clinical trial sponsors for Bardoxolone methyl
US Patents for Bardoxolone methyl
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| Bardoxolone methyl | Start Trial | Pyridyl analogs of 1-(2-cyano-3,12-dioxooleana-1,9(11)dien-28-oyl) imidazole | Trustees of Dartmouth College (Hanover, NH) | Start Trial |
| Bardoxolone methyl | Start Trial | Terpenoid derivatives | Daiichi Sankyo Company, Limited (Chuo-ku, JP) | Start Trial |
| Bardoxolone methyl | Start Trial | CDDO-compounds and combination therapies thereof | The Trustees of Dartmouth College (Hanover, NH) Board of Regents, The University of Texas System (Austin, TX) | Start Trial |
| Bardoxolone methyl | Start Trial | CDDO-compounds and combination therapies thereof | Board of Regents, The University of Texas System (Austin, TX) The Trustees of Dartmouth College (Hanover, NH) | Start Trial |
| Bardoxolone methyl | Start Trial | Antioxidant inflammation modulators: novel derivatives of oleanolic acid | Reata Pharmaceuticals, Inc. (Irving, TX) | Start Trial |
| Bardoxolone methyl | Start Trial | Antioxidant inflammation modulators: novel derivatives of oleanolic acid | Reata Pharmaceuticals, Inc. (Irving, TX) | Start Trial |
| Bardoxolone methyl | Start Trial | Triterpenoids and compositions containing the same | Trustees of Dartmouth College (Hanover, NH) | Start Trial |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for Bardoxolone methyl
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| Bardoxolone methyl | World Intellectual Property Organization (WIPO) | 2016033132 | 2034-08-26 | Start Trial |
| Bardoxolone methyl | European Patent Office | 2977381 | 2033-03-19 | Start Trial |
| Bardoxolone methyl | Japan | 6328102 | 2033-03-19 | Start Trial |
| Bardoxolone methyl | Japan | WO2014148455 | 2033-03-19 | Start Trial |
| Bardoxolone methyl | Taiwan | 201514192 | 2033-03-19 | Start Trial |
| Bardoxolone methyl | World Intellectual Property Organization (WIPO) | 2014148455 | 2033-03-19 | Start Trial |
| Bardoxolone methyl | Australia | 4324602 | 2020-11-28 | Start Trial |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
